10
Aug
2023
14:00
BST
09:00
EDT
Webinar
Applying the ESC / IC-OS Guidelines: How Do We Actually Do Risk Stratification?
-
Views:
1626
-
Likes:
5
Overview
In this month's Journal Club, Dr Daniela Cardinale (European Institute of Oncology, Milan, IT), Dr Anne Blaes (Masonic Cancer Center, Minneapolis, US), Prof Dan Lenihan (Saint Francis Healthcare System, US) and Prof Joe Carver (University of Pennsylvania, US) discuss “Applying the ESC / IC-OS Guidelines: How do we actually do risk stratification?”.
The broadcast will explore risk stratification principles in Cardio-Oncology and the significance of serum biomarkers and imaging in predicting risk for patients with newly diagnosed breast cancer. Presentations will delve into recommended biomarkers and imaging techniques for accurate risk assessment. Additionally, the broadcast will discuss the challenging task of risk stratifying patients who have undergone cancer treatment more than five years ago. The objectives of the broadcast include outlining the fundamental principles of cardiovascular risk stratification, emphasising the role of serum biomarkers and imaging in risk prediction, and addressing appropriate surveillance and follow-up measures for cancer survivors.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Support Statement
This is an independent activity run by the International cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Faculty:
Anne Blaes
Daniel Lenihan
Joe Carver
Daniela Cardinale
This broadcast is supported by
Faculty Biographies
Daniela Cardinale
Daniela Cardinale is director of the cardioncology unit at the European Institute of Oncology in Milan, IT where she has been working since 1994. Her professional experience and investigational interests focus on prevention, early detection, monitoring and treatment of cardiotoxicity; screening of cardiotoxicity in patients with cardiac disease; and malignant pericardial effusion evaluation and intrapericardial treatment. Dr Cardinale has been the vice-president of the International CardiOncology Society (ICOS) since 2009, and is a fellow of the European Society of Cardiology (ESC).
Anne Blaes
Dr Anne Blaes is a Professor in the Division of Hematology and Oncology at the University of Minnesota. She is the Director of the Screening, Prevention, Etiology, and Cancer Survivorship (SPECS) Program within the Masonic Cancer Center. She is an active medical oncologist with a special interest in the late effects of cancer therapy, particularly in the area of cardio-oncology. Her research focuses on designing and implementing strategies to help prevent the long term complications of treatments in our cancer survivors, particularly in the areas of cardiovascular health. She is the Chair for the American Society of Clinical Oncology’s Cancer Survivorship Committee, a member of the Executive Board for the Global Cardiooncology Society, associate editor for JACC Cardio-oncology, section editor for Hem/Onc Today on Survivorship and an active member of the ALLIANCE for Cancer Clinical Trials.
Daniel Lenihan
Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Joe Carver
Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.